[THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003523:Cycloserine; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D005000:Ethionamide; D007538:Isoniazid; D007612:Kanamycin; D011718:Pyrazinamide; D013307:Streptomycin; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary; D014756:Viomycin
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D011718:Pyrazinamide; D007612:Kanamycin; D010131:Aminosalicylic Acid; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin
AMINOSALICYLIC ACID; ANTIBIOTICS; CYCLOSERINE; DRUG RESISTANCE, MICROBIAL; ETHIONIAMIDE; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; STREPTOMYCIN; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY; VIOMYCIN
EL TRATAMIENTO DE LA TUBERCULOSIS CON DROGAS DE SEGUNDA L'INEA.